bioXXmed Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
bioXXmed Stock Forecast and Price Target
bioXXmed's stock price reaches the average target of 0.26€ by 2025 as expected recently by notable experts, there would be a potential downside of approximately -46.94% from the last closing price in May, 2024. This possible increase is based on a high estimate of 0.29€ and a low estimate of 0.23€. Even if you are not interested in T5O stock, you should still be aware of its competitors.
-46.94% Downside
bioXXmed Fair Value Forecast for 2023 - 2025 - 2030
bioXXmed's Price has increased by 100.00% In the last two years, going from 0.00€ to 0.00€. In the next year, analysts expect Fair Value to reach 0.52€ – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BNTX Stock Forecast | BioNTech | Outperform |
12
|
$89.95 | Buy/Sell | $123.75 | 11.77% |
| MOR Stock Forecast | MorphoSys | Outperform |
6
|
66.20€ | Buy/Sell | 28.78€ | 2.72% |
| EVT Stock Forecast | Evotec | Outperform |
14
|
9.74€ | Buy/Sell | 37.33€ | 161.81% |
| BIO3 Stock Forecast | Biotest | Hold |
9
|
29.30€ | Buy/Sell | 37.00€ | 26.28% |
| IMTX Stock Forecast | Immatics N.V. | Buy |
4
|
$10.81 | Buy/Sell | $19.83 | 85.01% |
bioXXmed Revenue Forecast for 2023 - 2025 - 2030
In the last two years, bioXXmed's Revenue has gone down from 40.00€k to 10000.00€ – a 75.00% drop. In the next year, 1 analysts estimate that bioXXmed's Revenue will decrease by 100.00%, reaching 0.00€. According to professional forecasts, in 2030, bioXXmed's Revenue will decrease by 100.00%, reaching 0.00€.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FYB Stock Forecast | Formycon | Buy |
11
|
40.95€ | Buy/Sell | 106.60€ | 119.78% |
| CVAC Stock Forecast | CureVac N.V. | Outperform |
6
|
$2.65 | Buy/Sell | $12.92 | 175.47% |
| HPHA Stock Forecast | Heidelberg Pharma | Buy |
11
|
3.01€ | Buy/Sell | 6.70€ | 275.42% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VSC Stock Forecast | 4SC | - |
4
|
7.90€ | Buy/Sell | 17.10€ | -100.00% |
| V3V Stock Forecast | VITA 34 | Hold |
10
|
4.94€ | Buy/Sell | 5.21€ | 7.29% |
| IFRX Stock Forecast | InflaRx N.V. | Outperform |
4
|
$1.41 | Buy/Sell | $9.44 | 390.78% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AFMD Stock Forecast | Affimed N.V. | Buy |
7
|
$5.33 | Buy/Sell | $5.25 | 203.00% |
| BNN Stock Forecast | BRAIN Biotech | Buy |
8
|
2.80€ | Buy/Sell | 11.23€ | 342.86% |
| MDG1 Stock Forecast | Medigene | Buy |
6
|
1.38€ | Buy/Sell | 2.68€ | 94.20% |
bioXXmed EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, bioXXmed's EBITDA has decreased by 54.44%, going from -1.80€M to -820.00€k. Next year, analysts are expecting EBITDA to reach -870.00€k – an increase of 6.10%. Over the next seven years, the forecast is for EBITDA to grow by 24.31%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 2INV Stock Forecast | 2invest | - |
0
|
7.50€ | Buy/Sell | 29.70€ | -100.00% |
| VVY Stock Forecast | Vivoryon Therapeutics N.V. | Outperform |
4
|
0.65€ | Buy/Sell | 34.38€ | 9130.77% |
| ALTME Stock Forecast | TME Pharma N.V. | - |
-23
|
0.26€ | Buy/Sell | 3.52€ | -100.00% |
bioXXmed EBIT Forecast for 2023 - 2025 - 2030
In the last two years, bioXXmed's EBIT has decreased from -1.82€M to -820.00€k – a 54.95% drop. For next year, analysts predict EBIT of -880.00€k, which would mean an increase of 7.32%. Over the next seven years, experts predict that bioXXmed's EBIT will grow at a rate of 25.88%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DBI Stock Forecast | Deutsche Biotech Innovativ | - |
6
|
1.35€ | Buy/Sell | 43.60€ | -100.00% |
| MGNK Stock Forecast | Mologen | - |
0
|
0.08€ | Buy/Sell | 0.00€ | -100.00% |
| SBH Stock Forecast | Sangui Biotech International | - |
0
|
0.00€ | Buy/Sell | 0.00€ | 0.00% |
bioXXmed EPS Price Prediction Forecast for 2023 - 2025 - 2030
bioXXmed's EPS has increased by 100.00% In the last two years, going from -0.49€ to 0.00€. In the next year, analysts expect EPS to reach -0.16€ – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CNW Stock Forecast | co.don | - |
8
|
0.02€ | Buy/Sell | 6.30€ | -100.00% |
| PA8 Stock Forecast | Paion | - |
6
|
0.03€ | Buy/Sell | 9.85€ | -100.00% |
| MF6 Stock Forecast | MagForce | - |
7
|
0.00€ | Buy/Sell | 11.86€ | 0.00% |
.jpg)